-
ISSCR Urges UK Agency to Increase Enforcement for the Marketing of Unproven Products
The ISSCR writes UK agency to urge for increased enforcement activities to prevent the marketing and commercialization of stem cell-related products.Full story -
ISSCR Comments on Need to Improve ClinicalTrials.gov Database to Prevent Abuse
The ISSCR issues a comment letter urging that more efforts must be made to prevent the ClinicalTrials.gov database from being abused by clinics marketing unproven stem cell interventions.Full story